DJIA 17,811.19 92.19 0.52%
NASDAQ 4,719.53 17.66 0.38%
S&P 500 2,062.54 9.79 0.48%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

37.03 0.43 (1.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $37.03 1.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.13
Previous Close $36.60
Daily Range $36.42 - $37.80
52-Week Range $30.80 - $55.99
Market Cap $4.6B
P/E Ratio -70.38
Dividend (Yield) $0.00 (0.0%)
Volume 646,415
Average Daily Volume 1,302,334
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

3 Biotech Stocks to Watch in November

Biotech can be a tough sector for many investors. Here, our analysts share their three favorite picks as we go into November.

Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape

Friday's ETF Movers: GDXJ, BBH

5 Stocks With Big Insider Buying

Seattle Genetics (SGEN) Shows Signs Of Being Water-Logged And Getting Wetter

5 Health Care Stocks Hurting From The Affordable Care Act

Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog

Seattle Genetics' (SGEN) CEO Clay Siegall on Q3 2014 Results - Earnings Call Transcript

Analysts' Actions: Aegerion, Atmel, Avon, Seattle Genetics, More

Seattle Genetics, Inc. Posts Record Adcetris Sales

A solid quarter for the biotech allowed it to raise guidance for the year.

See More SGEN News...

SGEN's Top Competitors

SGEN $37.03 (1.17%)
Current stock: SGEN
AMGN $161.88 (-0.49%)
Current stock: AMGN
CELG $108.51 (1.08%)
Current stock: CELG
GILD $100.68 (0.09%)
Current stock: GILD